In the latest video of our Cells series, part of the GOBOLDLY™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million Americans.
RA is a painful and crippling autoimmune disease that is, simply put, the body’s own immune system attacking the joints. With this disease, normally beneficial immune cells, called B cells and T cells, go “rogue,” attacking joints and causing inflammation and pain.
Over the last decade, we’ve seen a number of advancements in treatments for RA, including a new first-in-class oral medicine offering greater convenience for patients. But researchers at America’s biopharmaceutical companies aren’t stopping there. They are working tirelessly to develop more weapons to combat and destroy these rogue cells, with the hope of one day giving patients the opportunity for a life free of pain.
Robert Zirkelbach Robert Zirkelbach is Executive Vice President of Public Affairs at PhRMA. He joined PhRMA in 2014 after working for seven years representing the health insurance industry. He likes Saturday afternoon BBQs on his deck, traveling, trying new restaurants, and attempting to play golf. He’s an avid, somewhat obsessive, Iowa Hawkeye fan and is lucky to have a wife that loves watching college football on Saturday afternoons.